| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.2M | — | +51.7% |
| Cost of Revenue | $30.5M | — | +64.5% |
| R&D Expense | $26.2M | — | +5.8% |
| SG&A Expense | $25.7M | — | +39.5% |
| Operating Income | -$22.7M | — | -117.7% |
| Pre-tax Income | -$24.2M | — | -118.5% |
| Income Tax | $798K | — | -2.6% |
| Net Income | -$25.0M | — | -119.3% |
| EPS (Basic) | -$0.06 | — | -118.2% |
| EPS (Diluted) | -$0.11 | — | -135.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $215.6M | -13.2% | -12.3% |
| Current Assets | $288.8M | -12.3% | -2.1% |
| Total Assets | $645.0M | -6.3% | +9.8% |
| Current Liabilities | $73.3M | +2.2% | +22.1% |
| Total Liabilities | $184.3M | -17.9% | -3.3% |
| Stockholders' Equity | $460.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$26.3M | — | -36.9% |
| Capital Expenditures | $468K | — | +188.9% |
| Investing Cash Flow | -$3.1M | — | -1788.9% |
| Financing Cash Flow | -$3.2M | — | -104.8% |
| Free Cash Flow | -$26.7M | — | -38.1% |
| +16.0% |